Research Article
Effects of Preexisting Psychotropic Medication Use on a Cohort of Patients with Ischemic Stroke Outcome
| Characteristics | Prepsychotropic use () | Non-PPMU (control +PoMU) () | Unadjusted value |
| Gender, female | 47 (68.1%) | 95 (37.4%) | <0.001 | Age | 66 (57-76) | 67 (58-78) | 0.443 | Admission NIHSS | 3 (1-8.5) | 3 (1-7) | 0.352 | MRS on index presentation | 0 (0-2) | 0 (0-0) | <0.001 | IV tPA on index presentation | 12 (17.4%) | 62 (24.4%) | 0.26 | Thrombectomy | 9 (13.0%) | 25 (9.8%) | 0.442 | Decompressive craniectomy | 1 (1.4%) | 7 (2.8%) | 0.536 | Length of stay | 4 (3-7.5) | 4 (3-7) | 0.731 | Stroke volume (ml) | 1.4 (1.0-7.0) | 1.6 (1.0-13) | 0.312 | Discharge destination | | | 0.343 | Home | 32 (46.4%) | 115 (45.3%) | | Acute rehab | 26 (37.7%) | 113 (44.5%) | | Skilled nursing facility | 11 (15.9%) | 26 (10.2%) | | Preexisting risk factors | | | | HTN | 51 (73.9%) | 177 (69.7%) | 0.494 | Dyslipidemia | 47 (68.1%) | 155 (61.0%) | 0.280 | DM | 23 (33.3%) | 75 (29.5%) | 0.542 | History of TIA/stroke | 23 (33.3%) | 66 (26.0%) | 0.226 | Atrial fibrillation | 8 (11.6%) | 49 (19.3%) | 0.137 | CAD | 16 (23.2%) | 54 (21.3%) | 0.730 | PVD | 14 (20.3%) | 46 (18.1%) | 0.680 | Preadmission medications | | | | Statins | 42 (60.9%) | 121 (47.6%) | 0.051 | Antihypertensives | 47 (68.1%) | 156 (61.4%) | 0.307 | Antidiabetics | 17 (24.6%) | 58 (22.8%) | 0.753 | Antiplatelet | 31 (44.9%) | 122 (48.0%) | 0.647 | Anticoagulation | 5 (7.2%) | 18 (7.1%) | 0.964 | Lesion side | | | 0.756 | Right | 31 (44.9%) | 12 (44.1%) | | Left | 30 (43.5%) | 103 (40.6%) | | Both | 7 (10.1%) | 29 (11.4%) | | Lesion circulation | | | 0.001 | Anterior | 46 (66.7%) | 143 (56.3%) | | Posterior | 13 (18.8%) | 95 (37.4%) | | Both | 9 (13.0%) | 7 (2.8%) | | Hemorrhagic conversion | 6 (8.7%) | 22 (8.7%) | 0.993 |
|
|
Data are median (IQ range) and n (%).
|